Rockwell Medical (RMTI) Tops Q3 EPS by 8c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $0.62 --0%
EPS Growth %: -200.0%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -200.0%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q3 EPS of $0.09, $0.08 better than the analyst estimate of $0.01. Revenue for the quarter came in at $28.3 million versus the consensus estimate of $26.5 million.
GUIDANCE:
Rockwell Medical sees FY2024 revenue of $98-101 million, versus the consensus of $100.2 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- XORTX to voluntarily delist from TSX Venture Exchange
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
